BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28187032)

  • 1. Immunohistochemical Detection of Hematopoietic Cell-specific Protein-Tyrosine Phosphatase (Tyrosine Phosphatase SHP-1) in a Series of Endometrioid and Serous Endometrial Carcinoma.
    Giordano G; Campanini N; Goldoni M; Rodolfi AM; Brigati F; Merisio C; Berretta R
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):468-477. PubMed ID: 28187032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
    Alkushi A; Köbel M; Kalloger SE; Gilks CB
    Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma.
    Yano M; Ito K; Yabuno A; Ogane N; Katoh T; Miyazawa M; Miyazawa M; Hasegawa K; Narahara H; Yasuda M
    Mod Pathol; 2019 Jul; 32(7):1023-1031. PubMed ID: 30742011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
    Tassidis H; Brokken LJ; Jirström K; Ehrnström R; Pontén F; Ulmert D; Bjartell A; Härkönen P; Wingren AG
    Int J Cancer; 2010 May; 126(10):2296-307. PubMed ID: 19795453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
    Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival.
    Mahdi Z; Abdulfatah E; Pardeshi V; Hassan O; Schultz D; Morris R; Cote ML; Elshaikh MA; Bandyopadhyay S; Ali-Fehmi R
    Int J Gynecol Pathol; 2017 Sep; 36(5):405-411. PubMed ID: 28277313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components.
    Rossi ED; Bizzarro T; Monterossi G; Inzani F; Fanfani F; Scambia G; Zannoni GF
    Hum Pathol; 2017 Apr; 62():99-107. PubMed ID: 28041971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of Sam68 expression in endometrial carcinoma.
    Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
    Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
    Wu H; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
    Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
    Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas.
    Park JK; Otsuka N; Tomaru U; Suzuki H; Azuma M; Okamoto K; Yamashiro K; Kasahara M
    Hum Pathol; 2018 Oct; 80():104-112. PubMed ID: 29936059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
    Dellinger TH; Smith DD; Ouyang C; Warden CD; Williams JC; Han ES
    Gynecol Oncol; 2016 May; 141(2):336-340. PubMed ID: 26861585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epigenetic pathway related genes in association with PD-L1, ER/PgR and MLH1 in endometrial carcinoma.
    Saglam O; Cao B; Wang X; Toruner GA; Conejo-Garcia JR
    PLoS One; 2022; 17(2):e0264014. PubMed ID: 35226658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
    Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
    J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas.
    Miyamoto M; Takano M; Tsuda H; Soyama H; Aoyama T; Ishibashi H; Kato K; Iwahashi H; Matuura H; Yoshikawa T; Suzuki A; Hirata J; Furuya K
    Oncology; 2017; 93(1):29-35. PubMed ID: 28259868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral CD8+ Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer.
    Suemori T; Susumu N; Iwata T; Banno K; Yamagami W; Hirasawa A; Sugano K; Matsumoto E; Aoki D
    Int J Gynecol Cancer; 2015 Sep; 25(7):1165-72. PubMed ID: 26111272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.
    Agopiantz M; Forgez P; Casse JM; Lacomme S; Charra-Brunaud C; Clerc-Urmès I; Morel O; Bonnet C; Guéant JL; Vignaud JM; Gompel A; Gauchotte G
    Virchows Arch; 2017 Oct; 471(4):521-530. PubMed ID: 28836043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
    Shang P; Meng F; Liu Y; Chen X
    Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.